IFIG expression detects cellular activity (IFNα production by immune cells) and the classification of lupus patients that are similar clinically, leading to the development of diagnostic and prognostic biomarkers that will help physicians to select specific biological treatments. Here, IFNA1 is linked to systemic lupus erythematosus.